semaglutide sglt2 Effects of with and without concomitant inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial 📌 TYPE 2 DIABETES –

Treat these 90 days like a project

GLP1 OffRamp: Keep Results with a WeightedVest LoadReplacement Plan Why You Need an OffRamp GLP1 drugs like semaglutide and tirzepatide are powerfulyet as many as 36 % of patients regain a quarter of their lost weight within 12 months of stopping and 1 in 5 regain it all

Knowledge is power, and with the right tools, we can take control of our health before illness takes control of us. Introducing Glutaryl Your first product, Glutaryl, has been described as groundbreaking

The Phase 2 liver data showing 82% fat reduction provides strong rationale, but the Phase 3 endpoints are more demanding

Meal Inspiration : Add slices to toast, mix into salads, or blend into a smoothie for extra creaminess

Oral options are arriving, which means accessibility will stretch much wider